降血脂药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029934
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Antihyperlipidemic Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场概览

抗高血脂药物可降低血脂水平,降低患心脏病、肺动脉疾病和高胆固醇的风险。这些药物还可以通过减少脂质吸收来帮助身体去除粪便中多余的脂质。医生经常将抗高血脂药物与其他药物一起开出,以增加好胆固醇水平并降低坏胆固醇水平。患者的胆固醇状况和其他潜在状况使医生能够从各种选择中选择最佳的降血脂治疗。他汀类药物是最广泛使用的降血脂药物。患者可以根据身体的血脂水平使用烟酸、贝特类药物和胆汁酸螯合剂。这些降血脂药物都以不同的方式发挥作用;有些可能需要几周的时间才能影响身体,而另一些可能会产生负面影响。医生更喜欢使用保守措施来治疗血脂异常高的患者,包括改变饮食和活动。这是恢复患者理想健康和身体状况的最佳方法。但如果这些方法无效,医生会开降血脂药物,并根据患者的恢复情况调整剂量。

由于全球久坐生活方式的增加,对降血脂药物的需求正在上升。此外,随着胆固醇水平升高,心脏病和中风危险因素的激增预计将进一步促进市场增长。全球三分之一的缺血性心脏病病例是由高胆固醇引起的。据世界卫生组织称,胆固醇升高导致 2970 万人伤残调整生命年(DALYS),占所有伤残调整生命年(DALYS)的 2%,以及 260 万人死亡(占所有死亡人数的 4.5%)。此外,人们对使用降血脂药物的认识不断提高,也将在不久的将来推动降血脂药物市场的增长。

市场范围

“到2030年全球降血脂药物市场分析”是对制药行业的专业和深入研究,特别注重全球市场趋势分析。该报告旨在提供降血脂药物市场的概况,并按药物类别、分销渠道和地理位置进行详细的市场细分。该报告提供了主要降血脂药物市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

市场细分

降血脂药物市场根据药物类别、分销渠道和地区进行细分。根据药物类别,全球降血脂药物市场分为他汀类药物、胆汁酸螯合剂、胆固醇吸收抑制剂、纤维酸衍生物、PCSK9抑制剂、组合药物等。按分销渠道划分,降脂药市场分为医院药房、零售药房和网上药房。

市场动态

驱动程序-   

美国心脏协会声称, 20、胆固醇水平逐渐上升。女性 70 岁、男性 60 岁后,它们往往开始下降。此外,所有年龄段的女性平均 HDL-C 水平通常比所有男性高出约 10 毫克/分升。针对非他汀类药物使用者的新药物类别的出现、他汀类药物使用者数量的增加以及使用降脂药来降低心血管疾病 (CVD) 风险的建议是预计推动市场增长的一些原因。美国高脂血症指南规定了 21 岁以上有动脉粥样硬化性心血管疾病 (ASCVD) 风险的患者的他汀类药物剂量方案,这对于降脂药市场的扩张至关重要。因此,高胆固醇和甘油三酯水平的新合并症正在成为他汀类药物的目标群体的一部分。大多数降血脂药物都有轻微的副作用。然而,某些药物产生严重副作用的风险很高,例如 2 型糖尿病或肝损伤。即使在研究的后期阶段,由于副作用或无法提供足够的结果,CETP 抑制剂等药物类别也已被放弃或停止。因此,降脂药的风险对其进入降脂药市场构成了重大挑战。

Antihyperlipidemic Drugs Market: Strategic Insights

Antihyperlipidemic Drugs Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • ABBVIE
  • AMGEN INC.
  • ASTRAZENECA PLC.,
  • BRISTOL-MAYERS SQUIBB COMPANY
  • MERCK AND CO., INC.,
  • NOVARTIS AG
  • SANOFI S.A.,
  • PFIZER, INC.
  • MYLAN NV.

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

药物类别
  • 胆汁酸螯合剂
  • 胆固醇吸收抑制剂
  • 纤维酸衍生物
  • PCSK9 抑制剂
  • 组合等
分销渠道
  • 医院药房
  • 零售药房
  • 网上药房
地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲

降血脂药物市场以北美地区为主,到2022年该地区降血脂药物市场份额最大。由于心血管疾病和中风发病率的增加,预计北美降血脂药物市场将增长。例如,在美国,每年约有 795,000 起中风。因此,中风病例的增加推动了降血脂药物市场的区域增长。在过去的几年里,美国对降血脂药物的需求有所增加,因为血脂水平过高可能导致多种疾病,包括动脉阻塞和斑块,这可能会造成危及生命的后果。

欧洲是全球降血脂药物市场的第二大收入贡献者。由于该地区高脂血症发生率较高,预计该地区在预测期内将紧随北美。此外,生活方式的选择或潜在的医疗疾病是高脂血症的主要原因。据推测,肥胖、吸烟、缺乏运动等生活方式因素会导致高脂血症,而肾病、糖尿病等疾病也容易引起高脂血症。此外,老年人口的激增预计也会导致高脂血症患病率上升,因为老年人口更容易患心血管疾病、肾脏疾病等各种疾病,并可能推动全球降血脂药物市场的增长。

市场参与者< /p>

该报告涵盖了关键的降血脂药物市场的发展,例如有机和无机增长策略。多家公司,如艾伯维 (Abbvie)、安进公司 (Amgen, Inc)、阿斯利康 (AstraZeneca)、百时美施贵宝 (Bristol-Myers Squibb)、第一三共 (Daiichi Sankyo)、雷迪博士实验室 (Dr. Reddy's Laboratories)、默克 (Merck & nbsp;) 等。 Co. Inc.、Novartis AG、Mylan NV、Pfizer 等公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略活动包括收购、合作和收购。合作。这些活动为扩大市场参与者的业务和客户群铺平了道路。随着全球市场对疼痛治疗药物的需求不断增长,降血脂药物市场的参与者预计将获得利润丰厚的增长机会。

全球降血脂药物市场的主要发展

  • 2022 年 8 月,美国心脏病学会 (ACC) 特别工作组据 Esperion 称,专家共识决策路径 (ECDP) 推荐 bempedoic Acid (NEXLETOL) 作为一种重要的口服非他汀类药物治疗,用于降低动脉粥样硬化性心血管疾病 (ASCVD) 中的 LDL-胆固醇 (LDL-C)。
  • 2022年5月,Sun Pharma在印度推出口服降脂剂。建议正在服用最大可接受剂量他汀类药物的心脏病患者以及患有导致胆固醇水平升高的遗传性疾病的患者使用。
  • 2022 年 5 月,Zydus Lifesciences Limited 推出了 Bemdac(Bempedoic 酸),这是一类新的印度的口服药物。该药物为那些生活方式改变和服用最大耐受剂量的他汀类药物但低密度脂蛋白胆固醇 (LDL-c) 水平不受控制的患者引入了一种新的治疗方法,这是目前的治疗方法和控制血脂异常的基石。
  • 2021 年 12 月,诺华的 Leqvio (inclisiran) 获得美国食品和药物管理局 (FDA) 批准,这是一种一流的降低胆固醇的 siRNA。

该报告还包括降血脂药物市场中的主要公司概况、SWOT 分析以及降血脂药物市场规模。此外,该报告还重点介绍了领先的行业参与者,提供了公司简介、所提供的组件和服务、过去三年的财务信息以及过去五年的主要发展等信息。

Insight Partner 的专业研究和分析团队由具有高级统计专业知识的经验丰富的专业人士组成,并提供各种定制选项目前的研究。                

Antihyperlipidemic Drugs Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类别
  • 胆汁酸螯合剂
  • 胆固醇吸收抑制剂
  • 纤维酸衍生物
  • PCSK9 抑制剂
  • 组合等
By 分销渠道
  • 医院药房
  • 零售药房
  • 网上药房
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • ABBVIE
  • AMGEN INC.
  • ASTRAZENECA PLC.,
  • BRISTOL-MAYERS SQUIBB COMPANY
  • MERCK AND CO., INC.,
  • NOVARTIS AG
  • SANOFI S.A.,
  • PFIZER, INC.
  • MYLAN NV.
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies
    1. ABBVIE
    2. AMGEN INC.
    3. ASTRAZENECA PLC.,
    4. BRISTOL-MAYERS SQUIBB COMPANY
    5. MERCK AND CO., INC.,
    6. NOVARTIS AG
    7. SANOFI S.A.,
    8. PFIZER, INC.
    9. MYLAN NV.
    10. DR. REDDY'S LABORATORIES LTD

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports